Compound information
- Natural Products
- ZC1561485
- Molecular Formula
- C16H23BrN2O4S
- Molecular Weight
- 418.056190316 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-bromo-2-methyl-phenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C16H23BrN2O4S/c1-12-11-13(17)5-6-14(12)24(21,22)19-9-7-18(8-10-19)15(20)23-16(2,3)4/h5-6,11H,7-10H2,1-4H3
- InChI Key
- JVWFOOREECQGOE-UHFFFAOYSA-N
- SMILES
- Cc1cc(Br)ccc1S(=O)(=O)N1CCN(C(=O)OC(C)(C)C)CC1
- Source
- ZINC000044606444
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.562 |
LogS | -4.663 | LogD | 3.864 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.499 | Pgp substrate | 0.024 |
HIA | 0.976 | F20 % | 0.989 |
F30 % | 0.979 | Caco-2 | -4.547 |
MDCK | -4.956 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.943 | PPB | 98.297 |
VD | 2.647 | Fu | 0.766 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.128 | CYP1A2 substrate | 0.601 |
CYP2A6 substrate | 0.678 | CYP2B6 substrate | 0.729 |
CYP2C19 inhibitor | 0.966 | CYP2C19 substrate | 0.785 |
CYP2C8 substrate | 0.655 | CYP2C9 inhibitor | 0.645 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.321 |
CYP2D6 substrate | 0.768 | CYP2E1 substrate | 0.872 |
CYP3A4 inhibitor | 0.328 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.4 | CL | 6.355 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.843 | Hepatotoxicity | 0.999 |
Mutagenicity | 0.923 | Rat Oral Acute Toxicity | 0.158 |
FDAMDD | 0.106 | Skin Sensitization | 0.297 |
Carcinogenicity | 0.977 | Eye Corrosion | 0.083 |
Eye Irritation | 0.066 | Respiratory Toxicity | 0.804 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.605 | IGC50 | 3.985 |
LC50FM | 3.317 | LC50DM | 4.504 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.221 | NR-AR-LBD | 0.294 |
NR-AhR | 0.024 | NR-Aromatase | 0.696 |
NR-ER | 0.248 | NR-ER-LBD | 0.4 |
NR-PPAR-gamma | 0.131 | SR-ARE | 0.74 |
SR-ATAD5 | 0.379 | SR-HSE | 0.078 |
SR-MMP | 0.022 | SR-p53 | 0.033 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.